150 related articles for article (PubMed ID: 17493401)
21. Conduction of electrically elicited impulses in peripheral nerves of diabetic patients.
Tackmann W; Lehmann HJ
Eur Neurol; 1980; 19(1):20-9. PubMed ID: 7371650
[TBL] [Abstract][Full Text] [Related]
22. Ischemia and sensory nerve conduction in diabetes mellitus.
Horowitz SH; Ginsberg-Fellner F
Neurology; 1979 May; 29(5):695-704. PubMed ID: 571568
[TBL] [Abstract][Full Text] [Related]
23. Nerve conduction and autonomic nerve function in diabetic children. A 10-year follow-up study.
Solders G; Thalme B; Aguirre-Aquino M; Brandt L; Berg U; Persson A
Acta Paediatr; 1997 Apr; 86(4):361-6. PubMed ID: 9174220
[TBL] [Abstract][Full Text] [Related]
24. Electrophysiological changes in diabetic neuropathy: from subclinical alterations to disabling abnormalities.
Baba M; Ozaki I
Arch Physiol Biochem; 2001 Jul; 109(3):234-40. PubMed ID: 11880927
[TBL] [Abstract][Full Text] [Related]
25. Effects of chronic lithium treatment on the peripheral nervous system.
Faravelli C; Di Bernardo M; Ricca V; Benvenuti P; Bartelli M; Ronchi O
J Clin Psychiatry; 1999 May; 60(5):306-10. PubMed ID: 10362438
[TBL] [Abstract][Full Text] [Related]
26. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy.
Tkac I; Bril V
Diabetes Care; 1998 Oct; 21(10):1749-52. PubMed ID: 9773742
[TBL] [Abstract][Full Text] [Related]
27. Sensory axonal dysfunction in the upper and lower limb of diabetic patients and its relation to diabetic retinopathy.
Kimura H; Harada N; Suzuki S; Takeuchi T
Diabetes Res; 1987 Apr; 4(4):169-73. PubMed ID: 3621800
[TBL] [Abstract][Full Text] [Related]
28. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
[TBL] [Abstract][Full Text] [Related]
29. Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients.
Raccah D; Fabreguetts C; Azulay JP; Vague P
Diabetes Care; 1996 Jun; 19(6):564-8. PubMed ID: 8725852
[TBL] [Abstract][Full Text] [Related]
30. Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic control.
Pozzessere G; Rizzo PA; Valle E; Mollica MA; Meccia A; Morano S; Di Mario U; Andreani D; Morocutti C
Diabetes Care; 1988 Jun; 11(6):473-80. PubMed ID: 3402302
[TBL] [Abstract][Full Text] [Related]
31. Large electrodes improve nerve conduction repeatability in controls as well as in patients with diabetic neuropathy.
Tjon-A-Tsien AM; Lemkes HH; van der Kamp-Huyts AJ; van Dijk JG
Muscle Nerve; 1996 Jun; 19(6):689-95. PubMed ID: 8609917
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of central and peripheral neuropathy in patients with chronic obstructive pulmonary disease.
Aras YG; Aydemir Y; Güngen BD; Güngen AC
Int J Chron Obstruct Pulmon Dis; 2018; 13():1857-1862. PubMed ID: 29922052
[TBL] [Abstract][Full Text] [Related]
33. A 5-yr follow-up nerve conduction study for the detection of subclinical diabetic neuropathy in children with newly diagnosed insulin-dependent diabetes mellitus.
Lee SS; Han HS; Kim H
Pediatr Diabetes; 2010 Dec; 11(8):521-8. PubMed ID: 20723100
[TBL] [Abstract][Full Text] [Related]
34. Nerve conduction studies in adrenomyeloneuropathy.
Chaudhry V; Moser HW; Cornblath DR
J Neurol Neurosurg Psychiatry; 1996 Aug; 61(2):181-5. PubMed ID: 8708687
[TBL] [Abstract][Full Text] [Related]
35. The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy.
Veves A; Malik RA; Lye RH; Masson EA; Sharma AK; Schady W; Boulton AJ
Diabet Med; 1991 Dec; 8(10):917-21. PubMed ID: 1838042
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of TNF-α in peripheral neuropathy patients and its correlation with nerve conduction velocity in type 2 diabetes mellitus.
Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
Diabetes Metab Syndr; 2013; 7(4):238-42. PubMed ID: 24290092
[TBL] [Abstract][Full Text] [Related]
38. The sensitivity of sympathetic skin responses and standard electrophysiological methods in diagnosis of diabetic neuropathy.
Ozge A; Saraçoğlu M; Gürtekin Y; Erenoğlu NY; Akyatan MN
Electromyogr Clin Neurophysiol; 2000; 40(1):37-43. PubMed ID: 10782356
[TBL] [Abstract][Full Text] [Related]
39. Absence of the sensory action potential of the medial plantar nerve: a sensitive indicator of diabetic neuropathy.
Abraham RM; Abraham RR
Diabet Med; 1987; 4(5):469-74. PubMed ID: 2959440
[TBL] [Abstract][Full Text] [Related]
40. Is there a correlation between cardiac sympathetic neuropathy or diabetic somatic neuropathy and glycosylated haemoglobin or blood pressure in patients with non-insulin-dependent diabetes mellitus?
Okada S; Ishii K; Hamada H; Ichiki K; Tanokughi S; Ogino Y; Ota Z; Shimizu M; Hiraki Y
J Int Med Res; 1995; 23(6):467-72. PubMed ID: 8746614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
